If reports are to be believed, India is all set to block China’s Fosun Pharmaceutical Group’s proposed $1.3-...
iKang Healthcare Group, Inc., a major provider in China’s fast growing private preventive healthcare services mark...
C-Bridge Capital, a Chinese private equity firm targeting the healthcare sector, has closed its second fund, C-Bridge He...
Bionic ear implant maker Cochlear is expanding its global manufacturing capacity with a new $50 million facility in Chin...
In a new collaboration, ShangPharma Innovation, Inc. (SPII) is providing funding and other support to scientists at UC S...
Trovagene, Inc. has entered into an agreement with Novogene Co. Ltd., a leading global provider of genomic services and ...
Shanghai Fosun Pharmaceutical (Group) Co. will spend $73.5 million to set up a technology innovation incubator which wil...
The National Clinical Research Center for Cancer (NCRCC) in China has signed a deal with the Institute of Computing Tech...
Zai Lab Limited, a Shanghai-based innovative biopharmaceutical company has raised $30 million in a Series C preferred eq...
Vivace Therapeutics, an oncology-focused portfolio-based drug discovery and development company is has raised $40 millio...
iCarbonX, a Chinese health-related data mining and analysis firm, has joined a $8.4 million Series B financing round in ...
iKang Healthcare Group, Inc., a major provider in China's fast-growing private preventive healthcare services market, an...
Singapore: IBM Watson recently announced its plans to expand its partnership with Baheal Pharmaceutical, bringing Watson...
On 21st June, around one thousand Chinese yoga practitioners will celebrate the International Yoga Day in Beijing, follo...
GP Capital, a Shanghai-based investment firm backed by state-owned Shanghai International Group, has led a RMB200 millio...
A university hospital in Hunan province is developing an online service to accurately diagnose skin conditions in second...
CSL Limited has agreed to acquire 80 per cent equity of plasma-derived therapies manufacturer Wuhan Zhong Yuan Rui De Bi...
Legend Capital has led a RMB120 million (US$17 million) series B round in PhiSkin, a Shanghai-based aesthetic medical an...
